Author: Potì, Francesco; Pozzoli, Cristina; Adami, Maristella; Poli, Enzo; Costa, Lucio G.
Title: Treatments for COVID-19: emerging drugs against the coronavirus Cord-id: u3enawtb Document date: 2020_5_11
ID: u3enawtb
Snippet: The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent. Along with extensive public health measures, an unprecedented global effort in identifying effective drugs for the treatment is being implemented. Potential drug targets are emerging as the result of a fast-evolving understanding of SARS-Co
Document: The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent. Along with extensive public health measures, an unprecedented global effort in identifying effective drugs for the treatment is being implemented. Potential drug targets are emerging as the result of a fast-evolving understanding of SARS-CoV-2 virology, host response to the infection, and clinical course of the disease. This brief review focuses on the latest and most promising pharmacological treatments against COVID-19 currently under investigation and discuss their potential use based on either documented efficacy in similar viral infections, or their activity against inflammatory syndromes. Ongoing clinical trials are also emphasized. (www.actabiomedica.it)
Search related documents:
Co phrase search for related documents- aberrant excessive and acute respiratory distress syndrome: 1, 2, 3, 4, 5
- aberrant excessive and lung injury: 1
- abnormal coagulation and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- abnormal coagulation and adaptive innate: 1, 2
- abnormal coagulation and adaptive innate immunity: 1
- abnormal coagulation and liver damage: 1
- abnormal coagulation and lmwh low molecular weight heparin: 1, 2, 3
- abnormal coagulation and lopinavir ritonavir: 1
- abnormal coagulation and lopinavir ritonavir combination: 1
- abnormal coagulation and lopinavir ritonavir therapy: 1
- abnormal coagulation and low molecular weight: 1, 2, 3, 4, 5, 6, 7
- abnormal coagulation and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
- abnormal coagulation and lung damage: 1
- abnormal coagulation and lung dysfunction: 1
- abnormal coagulation and lung injury: 1, 2, 3, 4, 5
- abnormal coagulation and lung tissue: 1
- abnormal coagulation and lymphocyte count: 1, 2
Co phrase search for related documents, hyperlinks ordered by date